← Open Payments lookup

NABIL SIDDIQI: Open Payments

NPI 1982996484 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,236 in 55 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $743 · 2025 $1,236

Food & beverage: $1,236
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$282
ABBVIE INC.10$157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$157
Neurocrine BioSciences, Inc.5$129
E.R. Squibb & Sons, L.L.C.6$114
Vanda Pharmaceuticals Inc.3$70
Lundbeck LLC3$69
Janssen Pharmaceuticals, Inc3$66
Alkermes, Inc.3$56
Bausch Health US, LLC3$54

Products named: REXULTI, VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, INGREZZA, COBENFY, FANAPT, LYBALVI.

Industry payments across FL — which companies pay providers there.